Cubist Systematic Strategies, LLC Bio N Tech Se Transaction History

Cubist Systematic Strategies, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$90.91 - $112.75 $238,729 - $296,081	2,626 New	2,626 $277,000
Q2 2023 Aug 14, 2023	SELL	$102.58 - $129.66 $5.35 Million - $6.76 Million	-52,126 Reduced 77.94%	14,757 $1.59 Million
Q1 2023 May 15, 2023	BUY	$122.57 - $153.67 $6.11 Million - $7.66 Million	49,871 Added 293.15%	66,883 $8.33 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $1.35 Million - $2.11 Million	11,361 Added 201.04%	17,012 $2.56 Million
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $1.43 Million - $2.05 Million	-11,188 Reduced 66.44%	5,651 $762,000
Q2 2022 Aug 15, 2022	BUY	$123.25 - $186.24 $585,314 - $884,453	4,749 Added 39.28%	16,839 $2.51 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $691,471 - $1.27 Million	5,477 Added 82.82%	12,090 $2.06 Million
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $220,756 - $369,407	-1,019 Reduced 13.35%	6,613 $1.71 Million
Q3 2021 Nov 15, 2021	SELL	$205.93 - $447.23 $471,579 - $1.02 Million	-2,290 Reduced 23.08%	7,632 $2.08 Million
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $1.12 Million - $2.4 Million	9,922 New	9,922 $2.22 Million
Q1 2021 May 17, 2021	SELL	$85.73 - $119.5 $332,718 - $463,779	-3,881 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$72.71 - $129.54 $282,187 - $502,744	3,881 New	3,881 $316,000

362

39.7M

3.01M

2.01M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.